AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 13.7% in October

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 42,200 shares, a growth of 13.7% from the October 15th total of 37,100 shares. Based on an average daily trading volume, of 2,500 shares, the days-to-cover ratio is presently 16.9 days.

Institutional Trading of AstraZeneca

A hedge fund recently bought a new stake in AstraZeneca stock. Kennedy Capital Management LLC acquired a new position in shares of AstraZeneca PLC (OTCMKTS:AZNCF) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. Institutional investors own 40.87% of the company’s stock.

AstraZeneca Stock Down 1.8 %

Shares of AstraZeneca stock opened at $127.96 on Monday. AstraZeneca has a 12 month low of $118.16 and a 12 month high of $175.00. The stock’s fifty day simple moving average is $148.69 and its 200 day simple moving average is $155.30.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.